BALAXI PHARMACEUTICALS LIMITED — Others, 29-03-2025: Trading Window

Balaxi Pharmaceuticals has announced a board meeting to discuss the audited financial results for the fourth quarter and financial year ended March 31, 2025. In line with this, the trading window for designated persons and their immediate relatives will be closed from April 1, 2025, until 48 hours after the results are declared. This closure aims to maintain compliance with insider trading regulations and protect shareholder interests during this sensitive period. Investors should monitor how this impacts sentiment, as the upcoming results could lead to changes in stock performance and strategic outlook.